•Biogen announced it will move its experimental Alzheimer's drug, diranersen, to late-stage trials despite failing to meet the primary goal in a mid-stage study.
•Biogen's shares increased by over 6% in premarket trading following the announcement.
•Finance Minister Koo Yun-cheol stated that a threatened strike by the Samsung Electronics union poses a significant risk to economic growth and exports.
•Leaders of three of the largest U.S. public pension systems expressed major concerns over SpaceX's ownership and control setup ahead of its upcoming public listing.
•Pension officials from New York and California urged Elon Musk to remove provisions that would curb shareholder protections.
•OpenAI is exploring legal action against Apple due to frustration over a ChatGPT integration that failed to deliver expected subscribers and prominence.
•The Bank of England's deputy governor stated that initial stablecoin regulation plans may have been overly conservative and the bank is exploring alternatives.